Insmed
INSM
176 hedge funds and large institutions have $2.35B invested in Insmed in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 19 closing their positions.
100% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 19
34% more capital invested
Capital invested by funds: $1.75B → $2.35B (+$601M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
12% more funds holding
Funds holding: 157 → 176 (+19)
0.95% less ownership
Funds ownership: 111.01% → 110.06% (-0.95%)
5% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 56
18% less call options, than puts
Call options by funds: $16.4M | Put options by funds: $20M
Top Buyers
| 1 |
Millennium Management
New York
|
+$16.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.4M |
| 3 |
D.E. Shaw & Co
New York
|
+$8.75M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.17M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.04M |
Top Sellers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12.6M |
| 2 |
State Street
Boston,
Massachusetts
|
-$12.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.7M |
| 4 |
O
OrbiMed
New York
|
-$10.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.59M |
INSM Hedge Fund Activity: Q4 2019 in Review
176 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2019, worth a combined $2.35B — up 34% from $1.75B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new INSM positions and 19 closed out — a net gain of 19 holders — while 53 added to existing stakes and 56 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $16.8M. The largest seller was Credit Suisse, cutting an estimated $12.6M.
- 176 institutional investors held Insmed (INSM) as of Q4 2019, up from 157 in Q3 2019.
- Funds reported $2.35B of Insmed stock for Q4 2019, up 34% quarter-over-quarter.
- 38 funds opened new Insmed positions in Q4 2019 and 19 closed out, a net change of +19 holders.
- The largest Insmed buyer in Q4 2019 was Millennium Management, an estimated $16.8M added.
- The largest Insmed seller in Q4 2019 was Credit Suisse, an estimated $12.6M sold.
Based on aggregated 13F filings for Q4 2019.